Activity value 75china Buyer&Supplier,Last transaction date:
2026-06-30
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for shenzhen salubaris pharmaceuticals co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 24 transactions, with a transaction quantity of 2710.24 and a transaction weight of 1304.9.
YearTransactionsQuantityWeight
20258717523.615424.66
2026242710.241304.9
Bill of lading data
<
1/15
>
Trade date
2026/06/30
B/L No.
108388321050
Suppliers
shenzhen salubaris pharmaceuticals co.ltd.
Buyers
công ty cổ phần dược phẩm tenamyd
Product description
SODICA ESTERIL NO. CAS (NUMERO DE REGISTRO DEL CHEMICAL ABSTRACTS SERVICE) 56238 63 2 CALIDAD USP 38 ASPECTO FISICO POLVO BLANCO O AMARILLO PALIDO CONCENTRACION NLT 855 UG NMT 1000 UG DE CEFUROXIMA POR MG CALCULADO EN BASE ANHIDRA PUREZA 97 0 100 0% TIPO DE EMPAQUE 8 TIN POR 10 KG USO PARA LA FABRICACION DE MEDICAMENTOS DE USO HUMANO MARCA NO TIENE CANTIDAD 80
Expand
Hs code
3003200000
Product tags
medicaments consisting of other antibiotics
Product description
DE EXPIRACION 11 ENERO 2029 LOTE YS26059 FECHA DE MANUFACTURA 31 ENERO 2026 FECHA DE EXPIRACION 30 ENERO 2029 PRODUCTO CEFEPIME HLC Y LARGENINE NOMBRE COMERCIAL CEFEPIME HLC YLARGENINE PRINCIPIO ACTIVO CEFEPIMA CLORHIDRATO 1 19 G EQUIVALENTE A CEFEPIMA BASE 1 0 G CONCENTRACION NLT 47 2% Y NMT 60 3% DE CEFEPIME NLT 35 8% Y NMT 40 7% DE ARGENINE PUREZA 97.8 100.0% INDICACIONES TERAPEUTICAS INFECCIONES CAUSADAS POR BACTERIAS SUCEPTIBLES A LA CEFEPIMA TANTO GRAM POSITIVAS COMO GRAM NEGATIVAS FORMA FARMACEUTICA POLVO ESTERIL PARA RECONSTITUIR A SOLUCION INYECTABLE TIPO DE EMPAQUE 22 TINDE 10 KG USO PARA LA FABRICACION DE MEDICAMENTOS DE USO HUMANO MARCA NO TIENE CALIDAD FARMACOPEICA USPNF2021 Y PROPIA DEL FABRICANTE CANTIDAD 220 KILOGRAMOS
Expand
Trade date
2026/05/13
B/L No.
108237578150
Suppliers
shenzhen salubaris pharmaceuticals co.ltd.
Buyers
công ty cổ phần dược phẩm tenamyd
Hs code
3003200000
Product tags
medicaments consisting of other antibiotics
Product description
ESTERIL PARA RECONSTITUIR A SOLUCION INYECTABLE TIPO DE EMPAQUE 22 CAJAS DE 10 KG USO PARA LA FABRICACION DE MEDICAMENTOS DE USO HUMANO MARCA NO TIENE CANTIDAD 220 KILOGRAMOS PAIS DE ORIGEN CHINA(215) NOS ACOGEMOS AL DECRETO NUMERO 1881 DE 2021 MINISTERIO DE COMERCIO INDUSTRIA Y TURISMO ARTICULO 1¿ CAPITULO 30 ARANCEL DESGRAVADO 0% MERCANCIA EXENTA DEL IVA (ESTATUTO TRIBUTARIO) DECRETO EXTRAORDINARIO 624 DE 1989 MINISTERIO DE HACIENDA Y CREDITO PUBLICO ARTICULO 477. FECHA
Expand
Trade date
2026/04/13
B/L No.
108144213440
Suppliers
shenzhen salubaris pharmaceuticals co.ltd.
Buyers
công ty cổ phần dược trang thiết bị y tế bình định bidiphar
Hs code
3003200000
Product tags
medicaments consisting of other antibiotics
Product description
DO 560500 PEDIDO 66.26 DECLARACION 1 DE 1;. //FACTURA:4COVITA-26003, FECHA:18-03-2026, //LOTE:YS26020, FECHA MANUFACTURA:2026/01/12, FECHA EXPIRACION: 2029/01/11 , PRODUCTO: CEFEPIME HLC Y LARGENINE, NOMBRE COMERCIAL: CEFEPIME HLC Y LARGENINE, PRINCIPIOACTIVO: CEFEPIMA CLORHIDRATO 1,19 G, EQUIVALENTE A CEFEPIMA BASE 1,0 G, CONCENTRACION: NLT 47,2% Y NMT 60,3% DE CEFEPIME, NLT 35,8% Y NMT 40,7% DE ARGENINE,PUREZA:97.8 -100.0%, INDICACIONES TERAPEUTICAS: INFECCIONES CAUSADAS POR BACTERIAS SUCEPTIBLES A LA CEFEPIMA TANTO GRAM-POSITIVAS COMO GRAM-NEGATIVAS, FORMA FARMACEUTICA: POLVO ESTERIL PARA RECONSTITUIR A SOLUCION INYECTABLE, TIPO DE EMPAQUE: 11 CARTONES DE 10KG, USO: PARALA FABRICACION DE MEDICAMENTOS DE USO HUMANO, MARCA: NO TIENE, CANTIDAD: 110 KILOGRAMOS// PAIS DE ORIGEN: CHINA(215)// MERCANCIA EXENTA DE IVA, LEY NUMERO 2010 DE 2019, CONGRESO DE COLOMBIA ARTICULO 13 (ESTATUTO TRIBUTARIO) DECRETO EXTRAORDINARIO 624 DE 1989, MINISTERIO DE HACIENDA Y CREDITO PUBLICO ARTICULO 477
Expand
shenzhen salubaris pharmaceuticals co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as arginine,cefuroxime sodium,cefepime hcl.
According to the 52wmb.com global trade database, as of 2026-06-30, the company has completed 571 international trades,
with its main trading regions covering pakistan,vietnam,bangladesh etc.
The core products include HS29419090,HS30032059900,HS29419000 etc,
often transported via shenzhen,port hong kong, port hong kong hk etc,
and its main trading partners are laboratorios richet s.a.,công ty cổ phần dược phẩm am vi,vitalis s.a.c.i..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shenzhen salubaris pharmaceuticals co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.